The Landscape of Advanced Bladder Cancer: A Review of the Last 30-Years
Cora Sternberg MD, FACP
Cora Sternberg joins Alicia Morgans at the latest ASCO GU symposium to discuss the significant advancements in the treatment of advanced bladder cancer looking back over the last 30 years.
Morgan Roupret, MD, Ph.D.
Morgan Roupret joins Charles Ryan to speak about the increase in bladder cancer in younger individuals and in particular younger women. Dr. Roupret explains the clinical issues that challenge clinicians when managing younger bladder cancer patients.
Journal Club: The Evaluation of Cxbladder and Adjudication of Atypical Cytology
Siamak Daneshmand, MD
Sia Daneshmand discusses a study published in European Urology which evaluated the atypical cytologies to evaluate the performance of Cxbladder diagnostic tests to either rule out low-risk individuals or identify patients at a high risk of urothelial carcinoma.
Understanding differences in bladder cancer outcomes between men and women can help physicians tailor optimal treatment and follow-up strategies. A recent paper published by Richters et al. in Urologic Oncology: Seminars and Original Investigations studied the sex-specific mortality in bladder cancer patients.
Survival Differences Between Men and Women with Bladder Cancer Depend Strongly On Time Since Diagnosis
Anke Richters, PhD
Anke Richters et al. presented results of their study from the Netherlands at the Novel Technology and Techniques in Urothelial Cancer Diagnosis session at EAU 2019. The aim of the study was to assess how the survival difference between men and women diagnosed with bladder cancer varied over time since diagnosis.